Follow
Gurkan Mollaoglu
Gurkan Mollaoglu
Verified email at mssm.edu
Title
Cited by
Cited by
Year
MYC drives progression of small cell lung cancer to a variant neuroendocrine subtype with vulnerability to aurora kinase inhibition
G Mollaoglu, MR Guthrie, S Böhm, J Brägelmann, I Can, PM Ballieu, ...
Cancer cell 31 (2), 270-285, 2017
4602017
The lineage-defining transcription factors SOX2 and NKX2-1 determine lung cancer cell fate and shape the tumor immune microenvironment
G Mollaoglu, A Jones, SJ Wait, A Mukhopadhyay, S Jeong, R Arya, ...
Immunity 49 (4), 764-779. e9, 2018
1562018
Family matters: How MYC family oncogenes impact small cell lung cancer
J Brägelmann, S Boehm, MR Guthrie, G Mollaoglu, TG Oliver, ML Sos
Cell Cycle 16 (16), 1489-1498, 2017
792017
Downregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children
ND Beckmann, PH Comella, E Cheng, L Lepow, AG Beckmann, SR Tyler, ...
Nature communications 12 (1), 4854, 2021
522021
A shift in lung macrophage composition is associated with COVID-19 severity and recovery
ST Chen, MD Park, DM Del Valle, M Buckup, A Tabachnikova, ...
Science Translational Medicine 14 (662), eabn5168, 2022
48*2022
Quantitative comparison of a human cancer cell surface proteome between interphase and mitosis
N Özlü, MH Qureshi, Y Toyoda, BY Renard, G Mollaoglu, NE Özkan, ...
The EMBO journal 34 (2), 251-265, 2015
472015
Molecular states during acute COVID-19 reveal distinct etiologies of long-term sequelae
RC Thompson, NW Simons, L Wilkins, E Cheng, DM Del Valle, ...
Nature Medicine 29 (1), 236-246, 2023
352023
Targeting Macrophages with CAR T Cells Delays Solid Tumor Progression and Enhances Antitumor Immunity
AR Sánchez-Paulete, J Mateus-Tique, G Mollaoglu, SR Nielsen, A Marks, ...
Cancer Immunology Research 10 (11), 1354-1369, 2022
312022
Sampling the host response to SARS-CoV-2 in hospitals under siege
AW Charney, NW Simons, K Mouskas, L Lepow, E Cheng, J Le Berichel, ...
Nature Medicine 26 (8), 1157-1158, 2020
312020
CLIC4 and CLIC1 bridge plasma membrane and cortical actin network for a successful cytokinesis
ZCU Kagiali, N Saner, M Akdag, E Sanal, BS Degirmenci, G Mollaoglu, ...
Life science alliance 3 (2), 2020
272020
A translational genomics approach identifies IL10RB as the top candidate gene target for COVID-19 susceptibility
G Voloudakis, JM Vicari, S Venkatesh, GE Hoffman, K Dobrindt, W Zhang, ...
NPJ Genomic Medicine 7 (1), 52, 2022
15*2022
Education for the future
B Pietrzak, A Ward, MK Cheung, BA Schwendimann, G Mollaoglu, ...
Science 360 (6396), 1409-1412, 2018
132018
Circulating proteins to predict adverse COVID-19 outcomes
CY Su, S Zhou, E Gonzalez-Kozlova, G Butler-Laporte, ...
medRxiv, 2021.10. 04.21264015, 2021
42021
The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals
G Butler-Laporte, E Gonzalez-Kozlova, CY Su, S Zhou, T Nakanishi, ...
Clinical Proteomics 19 (1), 34, 2022
22022
Abstract B075: Spatial genomics identifies cancer cell cytokines regulating ovarian cancer immunity
G Mollaoglu, A Tepper, H Potak, L Pia, A Amabile, C Falcomata, ...
Cancer Research 84 (5_Supplement_2), B075-B075, 2024
2024
Abstract PR005: Identification of DNA Damage Repair genes controlling the immune landscape of breast tumors via spatial functional genomics
P Suri, J Habib, G Mollaoglu, L Pia, A Baccarini, B Brown, R Samstein
Cancer Research 84 (1_Supplement), PR005-PR005, 2024
2024
Identification of DNA Damage Repair genes controlling the immune landscape of breast tumors via spatial functional genomics
P Suri, J Habib, G Mollaoglu, L Pia, A Baccarini, B Brown, R Samstein
CANCER RESEARCH 84 (1), 2024
2024
Abstract B014: Spatial genomics identifies cancer cell cytokines regulating ovarian cancer immunity
G Mollaoglu, A Tepper, H Potak, L Pia, A Amabile, C Falcomata, ...
Cancer Immunology Research 11 (12_Supplement), B014-B014, 2023
2023
P53 is a direct regulator of the immune co-stimulatory molecule CD80
E Alibo, G Mollaoglu, M Dhainaut, R Zhao, S Rose, A Baccarini, ...
bioRxiv, 2021.05. 24.445214, 2021
2021
Lineage specifiers SOX2 and NKX2-1 inversely regulate tumor cell fate and neutrophil recruitment in lung cancer.
G Mollaoglu, A Jones, S Wait, A Mukhopadhyay, S Jeong, R Arya, ...
CANCER IMMUNOLOGY RESEARCH 8 (4), 117-117, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–20